Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
ResMed said today it won FDA 510(k) clearance for its AirMini continuous positive airway pressure device.
The San Diego, Calif.-based company touted the AirMini as the world’s smallest CPAP device, and said it plans to launch it later this year. Read more
A Pennsylvania state judge this week upheld a $13.7 million judgement in favor of plaintiffs in a pelvic mesh case against Johnson & Johnson subsidiary Ethicon.
The plaintiff in the case claims she suffered severe and irreversible injuries after being implanted with Ethicon’s pelvic mesh implant. Read more
Orthofix said today it won both FDA and European Union-based CE Mark approval for its next-gen CervicalStim and SpinalStim bone growth stimulators.
The Lewisville, Texas-based company said the devices use a low-level pulsed electromagnetic field to “activate and augment” the body’s natural healing process to promote post-operative spinal fusion. Read more
Johnson & Johnson today said it launched CareAdvantage, a system designed to aid healthcare systems and services shift to value-based programs and operations.
The New Brunswick, N.J.-based company touted the service as a “holistic, data-driven approach, grounded in insights” which aims to help companies shift to alternative payment models tied to quality or value. The company said it will be available immediately in the US, with a phased global rollout in the future. Read more
The US District Court for the Central District of California yesterday certified a class of investors suing Staar Surgical, alleging that it concealed problems at a California plant which resulted in receiving an FDA warning letter.
Judge Michael Fitzgerald granted certification to the suing investor group which bought shares in Staar between Nov. 1, 2013 and June 30, 2014, near the date when the FDA warning letter was released, according to court documents. Read more